Dual variable of drug loaded micelles in both particle and electrical charge on gastric cancer treatment

References

• Padmanabhan N, Ushijima T, Tan P. How to stomach an epigenetic insult: the gastric cancer epigenome. Nat Rev Gastroenterol Hepatol. 2017;14(8):467–478.
   PubMed Web of Science ®Google Scholar
• Liu H, Liu Y, Bian Z, et al. Circular RNA YAP1 inhibits the proliferation and invasion of gastric cancer cells by regulating the miR-367-5p/p27 Kip1 axis. Mol Cancer. 2018;17(1):151.
   PubMed Web of Science ®Google Scholar
• Nadauld LD, Garcia S, Natsoulis G, et al. Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer. Genome Biol. 2014;15(8):428.
   PubMed Web of Science ®Google Scholar
• Title AC, Hong SJ, Pires ND, et al. Genetic dissection of the miR-200-Zeb1 axis reveals its importance in tumor differentiation and invasion. Nat Commun. 2018;9(1):4671.
   PubMedGoogle Scholar
• Maeda H. Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity. Adv Drug Deliv Rev. 2015;91:3–6.
   PubMed Web of Science ®Google Scholar
• Ojha T, Pathak V, Shi Y, et al. Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors. Adv Drug Deliv Rev. 2017;119:44–60.
   PubMed Web of Science ®Google Scholar
• Yu M, Zheng J. Clearance pathways and tumor targeting of imaging nanoparticles. ACS Nano. 2015;9(7):6655–6674.
   PubMed Web of Science ®Google Scholar
• Dai Y, Xu C, Sun X, et al. Nanoparticle design strategies for enhanced anticancer therapy by exploiting the tumour microenvironment. Chem Soc Rev. 2017;46(12):3830–3852.
   PubMed Web of Science ®Google Scholar
• Jiang W, Huang Y, An Y, et al. Remodeling tumor vasculature to enhance delivery of intermediate-sized nanoparticles. ACS Nano. 2015;9(9):8689–8696.
   PubMed Web of Science ®Google Scholar
• Ju RJ, Cheng L, Qiu X, et al. Hyaluronic acid modified daunorubicin plus honokiol cationic liposomes for the treatment of breast cancer along with the elimination vasculogenic mimicry channels. J Drug Target. 2018;26(9):793–805.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Bae YH. Evaluation of drug penetration with cationic micelles and their penetration mechanism using an in vitro tumor model. Biomaterials. 2016;98:120–130.
   PubMed Web of Science ®Google Scholar
• Zhong Y, Goltsche K, Cheng L, et al. Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo. Biomaterials. 2016;84:250–261.
   PubMed Web of Science ®Google Scholar
• Qhattal HS, Hye T, Alali A, et al. Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes. ACS Nano. 2014;8(6):5423–5440.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Guo Z, Cao Z, et al. Endogenous albumin-mediated delivery of redox-responsive paclitaxel-loaded micelles for targeted cancer therapy. Biomaterials. 2018;183:243–257.
   PubMed Web of Science ®Google Scholar
• Zhang F, Zhang S, Pollack SF, et al. Improving paclitaxel delivery: in vitro and in vivo characterization of PEGylated polyphosphoester-based nanocarriers. J Am Chem Soc. 2015;137(5):2056–2066.
   PubMed Web of Science ®Google Scholar
• Meng LH, Zhang H, Hayward L, et al. Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1. Cancer Res. 2004;64(24):9086–9092.
   PubMed Web of Science ®Google Scholar
• Li X, Xu H, Dai X, et al. Enhanced in vitro and in vivo therapeutic efficacy of codrug-loaded nanoparticles against liver cancer. Int J Nanomedicine. 2012;7:5183–5190.
   PubMed Web of Science ®Google Scholar
• Lu Y, Li F, Xu T, et al. Tetrandrine prevents multidrug resistance in the osteosarcoma cell line, U-2OS, by preventing Pgp overexpression through the inhibition of NF-κB signaling. Int J Mol Med. 2017;39(4):993–1000.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang L, Fai Chan H, et al. Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells. Sci Rep. 2017;7:46057.
   PubMed Web of Science ®Google Scholar
• Li XY, Zhao Y, Sun MG, et al. Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma. Biomaterials. 2014b;35(21):5591–5604.
   PubMed Web of Science ®Google Scholar
• Wang X, Cheng L, Xie HJ, et al. Functional paclitaxel plus honokiol micelles destroying tumour metastasis in treatment of non-small-cell lung cancer. Artif Cells Nanomed Biotechnol. 2018;46(sup2):1154–1169.
   PubMed Web of Science ®Google Scholar
• Kong L, Cai FY, Yao XM, et al. RPV-modified epirubicin and dioscin co-delivery liposomes suppress non-small cell lung cancer growth by limiting nutrition supply. Cancer Sci. 2020;111(2):621–636.
   PubMed Web of Science ®Google Scholar
• Liu JJ, Tang W, Fu M, et al. Development of R8 modified epirubicin-dihydroartemisinin liposomes for treatment of non-small-cell lung cancer. Artif Cells Nanomed Biotechnol. 2019b;47(1):1947–1960.
   PubMed Web of Science ®Google Scholar
• Li XT, Tang W, Xie HJ, et al. The efficacy of RGD modified liposomes loaded with vinorelbine plus tetrandrine in treating resistant brain glioma. J Liposome Res. 2019;29(1):21–34.
   PubMed Web of Science ®Google Scholar
• Seidlitz T, Merker SR, Rothe A, et al. Human gastric cancer modelling using organoids. Gut. 2019;68(2):207–217.
   PubMed Web of Science ®Google Scholar
• Yang H, Zhang H, Ge S, et al. Exosome-derived miR-130a activates angiogenesis in gastric cancer by targeting C-MYB in vascular endothelial cells. Mol Ther. 2018;26(10):2466–2475.
   PubMed Web of Science ®Google Scholar
• Marcucci F, Stassi G, De Maria R. Epithelial-mesenchymal transition: a new target in anticancer drug discovery. Nat Rev Drug Discov. 2016;15(5):311–325.
   PubMed Web of Science ®Google Scholar
• Liu J, Wang Q, Adu-Frimpong M, et al. Preparation, in vitro and in vivo Evaluation of Isoliquiritigenin-loaded TPGS modified proliposomes. Int J Pharm. 2019a;563:53–62.
   PubMed Web of Science ®Google Scholar
• Banerjee P, Geng T, Mahanty A, et al. Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors. Int J Pharm. 2019;557:374–389.
   PubMedGoogle Scholar
• Cheng B, Pan H, Liu D, et al. Functionalization of nanodiamond with vitamin E TPGS to facilitate oral absorption of curcumin. Int J Pharm. 2018;540(1-2):162–170.
   PubMedGoogle Scholar
• Choudhury H, Gorain B, Pandey M, et al. Recent advances in TPGS-based nanoparticles of docetaxel for improved chemotherapy. Int J Pharm. 2017;529(1-2):506–522.
   PubMed Web of Science ®Google Scholar
• Dosio F, Arpicco S, Stella B, et al. Hyaluronic acid for anticancer drug and nucleic acid delivery. Adv Drug Deliv Rev. 2016;97:204–236.
   PubMed Web of Science ®Google Scholar
• Ravar F, Saadat E, Gholami M, et al. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation. J Control Release. 2016;229:10–22.
   PubMed Web of Science ®Google Scholar
• Sun D, Zhou JK, Zhao L, et al. Novel curcumin liposome modified with hyaluronan targeting CD44 plays an anti-leukemic role in acute myeloid leukemia in vitro and in vivo. ACS Appl Mater Interfaces. 2017;9(20):16857–16868.
   PubMed Web of Science ®Google Scholar
• Gorelick-Ashkenazi A, Weiss R, Sapozhnikov L, et al. Caspases maintain tissue integrity by an apoptosis-independent inhibition of cell migration and invasion. Nat Commun. 2018;9(1):2806.
   PubMedGoogle Scholar
• Zamaraev AV, Kopeina GS, Prokhorova EA, et al. Post-translational modification of caspases: the other side of apoptosis regulation. Trends Cell Biol. 2017;27(5):322–339.
   PubMed Web of Science ®Google Scholar
• Ye G, Huang K, Yu J, et al. MicroRNA-647 targets SRF-MYH9 axis to suppress invasion and metastasis of gastric cancer. Theranostics. 2017;7(13):3338–3353.
   PubMed Web of Science ®Google Scholar
• Croft DR, Olson MF. Regulating the conversion between rounded and elongated modes of cancer cell movement. Cancer Cell. 2008;14(5):349–351.
   PubMed Web of Science ®Google Scholar
• Sanz-Moreno V, Gadea G, Ahn J, et al. Rac activation and inactivation control plasticity of tumor cell movement. Cell. 2008;135(3):510–523.
   PubMed Web of Science ®Google Scholar
• Wu HB, Yang S, Weng HY, et al. Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells. Autophagy. 2017;13(9):1528–1542.
   PubMed Web of Science ®Google Scholar
• Ju RJ, Li XT, Shi JF, et al. Liposomes, modified with PTD(HIV-1) peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer. Biomaterials. 2014;35(26):7610–7621.
   PubMed Web of Science ®Google Scholar
• Feng Q, Zhang C, Lum D, et al. A class of extracellular vesicles from breast cancer cells activates VEGF receptors and tumour angiogenesis. Nat Commun. 2017;8:14450.
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhang Y, Iwamoto H, et al. Discontinuation of anti-VEGF cancer therapy promotes metastasis through a liver revascularization mechanism. Nat Commun. 2016;7:12680.
   PubMed Web of Science ®Google Scholar
• Li X, Deng D, Xue J, et al. Quantum dots based molecular beacons for in vitro and in vivo detection of MMP-2 on tumor. Biosens Bioelectron. 2014a;61:512–518.
   PubMed Web of Science ®Google Scholar
• Wang Y, Lin T, Zhang W, et al. A prodrug-type, MMP-2-targeting nanoprobe for tumor detection and imaging. Theranostics. 2015;5(8):787–795.
   PubMed Web of Science ®Google Scholar
• Eastham AM, Spencer H, Soncin F, et al. Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res. 2007;67(23):11254–11262.
   PubMed Web of Science ®Google Scholar
• Neelakantan D, Zhou H, Oliphant MUJ, et al. EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells. Nat Commun. 2017;8:15773.
   PubMed Web of Science ®Google Scholar
• Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20(2):69–84.
   PubMed Web of Science ®Google Scholar
• Pastushenko I, Brisebarre A, Sifrim A, et al. Identification of the tumour transition states occurring during EMT. Nature. 2018;556(7702):463–468.
   PubMed Web of Science ®Google Scholar